HDFC Dividend Yield Fund
The scheme seeks to provide capital appreciation and/or dividend distribution by predominantly investing in a well-diversified portfolio of equity and equity related instruments of dividend yielding companies.
Growthvine rating: 3/5 — ranked #5 of 10 in category.
Fund basics
| Category | Equity: Dividend Yield |
|---|
| NAV | ₹23.28 (as of 2026-10-23) |
|---|
| AUM | ₹5,274 Cr |
|---|
| Expense ratio | 1.59% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Gopal Agrawal |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 11.05% |
|---|
| Sharpe ratio | 0.25 |
|---|
| Standard deviation | 15.87% |
|---|
| Max drawdown | −20.39% |
|---|
| Alpha | -0.25 |
|---|
| Beta | 1 |
|---|
Over 5 years, captured 88.7% of NIFTY Dividend Opportunities 50's upside and 78.5% of its downside.
Market cap allocation
| Large cap | 62.8% |
|---|
| Mid cap | 13.2% |
|---|
| Small cap | 24.1% |
|---|
Concentration
| Top 5 holdings | 19.3% |
|---|
| Top 10 holdings | 30.6% |
|---|
| Total holdings | 128 |
|---|
Top holdings
- ICICI Bank Ltd. — 5.4%
- HDFC Bank Ltd. — 5.0%
- AXIS Bank Ltd. — 3.7%
- Larsen & Toubro Limited — 2.6%
- Bharti Airtel Ltd. — 2.6%
- Kotak Mahindra Bank Ltd. — 2.5%
- Reliance Industries Ltd — 2.3%
- Tech Mahindra Limited — 2.2%
- Maruti Suzuki India Ltd. — 2.2%
- Sun Pharmaceutical Industries Ltd. — 2.1%
Top sectors
- Banking & Financial — 21.7%
- Automobile — 8.4%
- Software & Services — 7.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −7.9% | Q2 | #4 of 9 |
| 2025 | 3.3% | Q3 | #6 of 9 |
| 2024 | 16.2% | Q3 | #6 of 9 |
| 2023 | 38.0% | Q2 | #3 of 7 |
| 2022 | 6.9% | Q1 (Top) | #2 of 6 |